PTC Therapeutics Stock (NASDAQ: PTCT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 692.63K |
Day Range | - - - |
52 Wk Range | 17.53 - 40.69 |
Market Cap | $2.82B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 67 |
Short Interest | 11.39% |
Days to Cover | 13.22 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of PTC Therapeutics (NASDAQ:PTCT) through any online brokerage.
Other companies in PTC Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), SpringWorks Therapeutics (NASDAQ:SWTX) and TG Therapeutics (NASDAQ:TGTX).
PTC Therapeutics has a consensus price target of $39.16.
The stock price for PTC Therapeutics (NASDAQ: PTCT) is $36.64 last updated September 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for PTC Therapeutics.
PTC Therapeutics’s Q3 earnings are confirmed for Thursday, October 24, 2024.
There is no upcoming split for PTC Therapeutics.
PTC Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.